Antimicrobial and anti-inflammatory activities of chemokine CXCL14-derived antimicrobial peptide and its analogs
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1861 (1) , 256-267
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education (2015R1D1A1A01057988)
- Ministry of Science, ICT and Future Planning (2018R1A2B6003250)
- National Research Foundation of Korea
This publication has 28 references indexed in Scilit:
- Antimicrobial Activities of Chemokines: Not Just a Side-Effect?Frontiers in Immunology, 2012
- Application of N–C- or C–N-directed sequential native chemical ligation to the preparation of CXCL14 analogs and their biological evaluationBioorganic & Medicinal Chemistry, 2011
- Effect of Membrane Composition on Antimicrobial Peptides Aurein 2.2 and 2.3 From Australian Southern Bell FrogsBiophysical Journal, 2009
- Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm FormationInfection and Immunity, 2008
- Activities of Antimicrobial Peptides and Synergy with Enrofloxacin against Mycoplasma pulmonisAntimicrobial Agents and Chemotherapy, 2007
- Biological and structural characterization of new linear gomesin analogues with improved therapeutic indicesPeptide Science, 2006
- Antimicrobial and host-defense peptides as new anti-infective therapeutic strategiesNature Biotechnology, 2006
- Effect of Antibiotic Class and Concentration on the Release of Lipopolysaccharide from Escherichia coliThe Journal of Infectious Diseases, 1993
- Minimal peptide length for interaction of amphipathic .alpha.-helical peptides with phosphatidylcholine liposomesBiochemistry, 1991
- Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.Journal of Clinical Investigation, 1989